北京大学学报(医学版) ›› 2023, Vol. 55 ›› Issue (4): 748-754. doi: 10.19723/j.issn.1671-167X.2023.04.029

• 疑难/罕见病例分析 • 上一篇    下一篇

真菌性腹膜透析导管出口感染合并隧道感染1例

乔婕,芦丽霞,何玉婷,门春翠,楚新新,武蓓,赵慧萍*(),王梅   

  1. 北京大学人民医院肾内科,北京 100044
  • 收稿日期:2021-11-10 出版日期:2023-08-18 发布日期:2023-08-03
  • 通讯作者: 赵慧萍 E-mail:huipingzhao2009@163.com
  • 基金资助:
    北京大学人民医院研究与发展基金(RDN 2013-02)

Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report

Jie QIAO,Li-xia LU,Yu-ting HE,Chun-cui MEN,Xin-xin CHU,Bei WU,Hui-ping ZHAO*(),Mei WANG   

  1. Department of Nephrology, Peking University People's Hospital, Beijing 100044, China
  • Received:2021-11-10 Online:2023-08-18 Published:2023-08-03
  • Contact: Hui-ping ZHAO E-mail:huipingzhao2009@163.com
  • Supported by:
    Research and Development Fund of People's Hospital of Peking University(RDN 2013-02)

RICH HTML

  

摘要:

腹膜透析(peritoneal dialysis, PD)导管相关感染(即出口感染和隧道感染)是PD相关腹膜炎的主要诱因之一,如不能有效控制,严重者可导致腹膜透析导管拔除、腹膜透析技术失败,因此积极预防和及时有效的诊治以减少导管相关感染是PD患者日常管理的重要目标。腹膜透析导管出口感染和隧道感染可由多种微生物引起,以细菌为主,真菌极为罕见,目前可用来指导治疗的公开数据很少,且国内尚未见报道。一旦继发真菌性腹膜炎,患者只能退出腹膜透析治疗。现将北京大学人民医院肾内科成功诊治的1例真菌性腹膜透析导管出口感染合并隧道感染的病例分享如下, 患者女性,71岁,因“腹膜透析5年,出口处分泌物8天,加重1天”就诊。患者5年间多次患腹膜炎、PD导管出口感染及隧道感染,涉及多种病原体。8 d前评估患者出口见白色黏稠分泌物,距出口1 cm处皮肤暗红、发硬,浅层涤纶套完全脱出、摩擦出口边缘,Schaefer出口评分3分。因2个月前可疑出口感染,分泌物培养铜绿假单胞菌阳性,故再次留取分泌物细菌培养后,每日1次局部使用庆大霉素注射液外敷经验性治疗。1 d前评估出口发现皮下隧道段距出口2.5 cm处明显肿胀、轻压痛,可见白色中量黏稠分泌物,出口评分4分。化验腹膜透析流出液常规(-);先后两次复查出口分泌物细菌培养,近平滑念珠菌均阳性,故真菌性PD导管出口感染合并隧道感染诊断明确。立即寻找出口、隧道感染的原因及诱因,发现患者足部可疑灰趾甲病史,此次趾甲涂片真菌阳性、可见菌丝;并每日用手洗脚,同时每天坐矮板凳洗衣服,使出口及隧道长期受到挤压。基于上述诱因,给予综合性治疗:针对出口、隧道真菌感染,根据药敏结果给予氟康唑全身用药、辅以出口局部碘伏消毒后硝酸咪康唑乳膏外用;针对脱出的浅层涤纶套, 局部予每日碘伏消毒;同时予足部局部抗真菌治疗。治疗期间密切随访,每2~3天评估出口,并留存出口照片以动态观察疗效。总疗程14 d后,出口评分持续0~1分,复查出口处细菌培养阴性,涤纶套培养阴性,隧道B超正常,故更改为常规出口护理。每月规律随访,60个月未再发生出口及隧道感染。真菌性PD导管出口感染、隧道感染是腹膜透析的少见并发症,当进行规范的抗感染治疗无效时, 要考虑到真菌感染的可能,从而避免因为按细菌感染治疗,延长抗生素的应用时间,加重真菌感染,甚至进展至真菌性腹膜炎,退出腹膜透析。准确的出口评估有助于出口、隧道感染的及时诊断、尽早治疗。在治疗前行出口分泌物细菌培养及药敏试验有助于确定病原体、调整后续治疗;同时,为排除污染所致的真菌培养阳性,需要重复细菌培养。一旦确诊为真菌性导管相关感染,应积极寻找可能诱因,针对性且全面的治疗对患者的预后有决定作用。

关键词: 腹膜透析, 出口感染, 隧道感染, 真菌

Abstract:

Peritoneal dialysis (PD) catheter-related infection (i.e. exit-site infection and tunnel infection) is one of the main causes of PD-related peritonitis. If it cannot be controlled effectively, it could lead to PD technique failure. Therefore, timely and effective diagnosis and treatment and active prevention so as to reduce PD catheter-related infection is an important treatment goal in PD patients. PD catheter exit-site infection (ESI) and tunnel infection can be caused by a variety of microorganisms, mainly bacteria, while fungi are very rare. Few public data can be used to guide treatment of PD catheter-related fungal infection, and there is no related report in China till now. Once fungal peritonitis occurred, the patient can only withdraw from PD treatment. Here, we report a case of fungal PD catheter ESI combined with tunnel infection which was successfully diagnosed and treated in our PD center. A 71-year-old woman came to clinic because of "PD for 5 years, secretions from exit site for 8 days and aggravation for 1 day". The patient suffered from peritonitis, ESI and tunnel infection for many times in the past 5 years, involving a variety of pathogens. Eight days before, she found white viscous discharge from exit site. The subcutaneous cuff completely came out of it and rubbed its skin. The Schaefer exit-site score was 3 points. Due to the suspected ESI 2 months before, the discharge swab for bacterial culture was positive for Pseudomonas aeruginosa, so the exit site swab for bacterial culture was done again, and gentamicin injection was applied topically once a day for empirical treatment. The exit site was evaluated one day before: The subcutaneous tunnel was significantly swollen and slightly tender at 2.5 cm away from the exit site, and with white medium amount of viscous secretions. The exit-site score increased to 4 points. Routine test of dialysis effluent was (-). The bacterial culture of the exit-site discharge was rechecked twice, and Candida parapsilosis was positive for two times, so the diagnosis of fungal PD catheter ESI combined with tunnel infection was clear. Immediately we searched for the causes of ESI and tunnel infection. We found that the patient had a suspicious history of gray toenail on the foot. The toenail smear was positive for fungi and visible hyphae. She washed feet with hands every day, and washed clothes on a low bench every day, which made the exit-site and tunnel squeezed for a long time. Based on the above causes, we gave her comprehensive treatment as follows: For ESI and tunnel fungal infections, fluco-nazole was used systemically according to the drug sensitivity results, and miconazole cream was applied to the exit-site locally. For the subcutaneous cuff that came out completely, daily iodophor disinfection was given locally. At the same time, local antifungal treatment was given to the foot. We followed up closely during treatment, evaluated the exit-site every 2-3 days, and took photos of the exit-site to dynamically observe the effect. After 14 days of treatment, the exit-site score continued to be 0-1, the bacterial culture of the exit-site was negative, the cuff culture was negative, and the tunnel B-ultrasound was normal. The patient had been followed up regularly once a month for 60 months, no ESI and tunnel infection occurred. Fungal PD catheter ESI and tunnel infection are rare complications of PD. When the standard anti-infection treatment is ineffective, the possibility of fungal infection should be considered, so as to avoid prolonged use of antibiotics, aggravating fungal infection, and even progressing to fungal peritonitis, leading to withdrawal from PD. Accurate exit-site evaluation is helpful for timely diagnosis and early treatment of ESI and tunnel infection. The exit-site discharge culture and drug sensitivity test before treatment are helpful to identify the pathogen and adjust subsequent treatment. At the same time, repeated discharge culture is required in order to exclude positive fungal culture results caused by contamination. Once fungal catheter-related infection is diagnosed, we should search for possible causes actively, subsequent targeted and comprehensive treatment plays a decisive role for the prognosis of patients.

Key words: Peritoneal dialysis, Exit-site infection, Tunnel infection, Fungus

中图分类号: 

  • R459.5

表1

患者既往腹膜透析相关感染情况"

No. PD duration/
months
PD-related
infection
Schaefer
exit-site
score
Bacterial culture Tunnel
B-ultrasound
Cause Treatment and outcome
1 23 Peritonitis 0 point Staphylococcus warneri Not done Improper PD exchange operation Cefazolin 1.0 g+ceftriaxone 1.0 g, qd, IP for 2 weeks, cured
2 37 ESI and tunnel infection 5 points Enterobacter cloacae Indicate infection The button on the self-made abdominal strap was squeezed Diluted iodophor+ mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
3 40 ESI and tunnel infection 5 points Actinomyces (medium) Indicate infection The distance between the subcutaneous cuff and the exit-site < 1 cm; Tunnel was compressed Diluted iodophor+ mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
4 52 Peritonitis 0 point Bacillus cereus Not done Constipation, improper PD exchange operation Cefazolin 1.0 g+ceftriaxone 1.0 g, qd, IP for 3 weeks, cured
5 53 Tunnel infection 4 points Culture negative Indicate infection Subcutaneous cuff half came out; Use a towel to wrap around her waist when sleeping and the tunnel was squeezed Mupirocin qd used locally; Cefuroxime 0.25 g bid orally for 2 weeks, cured
6 55 Suspected ESI 2 points Pseudomonas aeruginosa Not done Subcutaneous cuff completely came out of the exit site and rubbed the skin Mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
7 57 Suspected ESI 2 points Pseudomonas aeruginosa (small amount)Hemolytic staphylococcus (small amount) Not done Subcutaneous cuff completely came out and rubbed the skin Mupirocin qd used locally; Levofloxacin 0.2 g qd oral for 2 weeks, cured
8 58
(2 months
before this
visit)
Suspected ESI 3 points Pseudomonas aeruginosa (small amount) Not done Subcutaneous cuff completely came out and rubbed the skin Gentamicin 2 mL qd externally for 3 weeks, cured

图1

患者出口感染合并隧道感染"

表2

患者真菌性出口感染及隧道感染治疗前后的出口评估"

Time Exit-site evaluation Tunnel evaluation Schaefer
exit-site
score
Tunnel B-ultrasound
Day0
    (the day of begining
    antifungal treatment)
White, medium amount of viscous secretions At a distance of 2.5 cm from the exit-site in the tunnel, tenderness (+), and the range of tunnel redness and swelling was 4 cm×2.5 cm 4 points Low echo surrounding the catheter near the exit-site, considering infection changes
Day2
    (after antifungal treatment)
Chartreuse, medium amount of viscous secretions At a distance of 1.5 cm from the exit-site in the tunnel, tenderness (+), and the range of tunnel redness and swelling was 4 cm×1.5 cm 4 points Considering tunnel infection
Day3 Chartreuse, small amount of secretion, locally dry No tenderness in the tunnel, with the range of redness and swelling was 2 cm×1 cm 2 points -
Day4 Very little chartreuse secretion, locally dry No tenderness in the tunnel, with the swelling range of 1 cm×1 cm 2 points -
Day5 No discharge No tenderness or swelling in the tunnel 0 point -
Day7-Day14 No discharge No tenderness or swelling in the tunnel 0 point Normal

图2

患者真菌性出口感染及隧道感染的诊疗过程"

1 Szeto CC , Li PK , Johnson DW , et al. ISPD catheter-related infection recommendations: 2017 update[J]. Perit Dial Int, 2017, 37 (2): 141- 154.
doi: 10.3747/pdi.2016.00120
2 Meng C , Beco A , Oliveira A , et al. Peritoneal dialysis cuff-shaving: A salvage therapy for refractory exit-site infections[J]. Perit Dial Int, 2019, 39 (3): 276- 281.
doi: 10.3747/pdi.2018.00193
3 Jhawar MS , Das J , George P , et al. CAPD catheter exit-site and tunnel infection with fungal etiology-treatment and catheter reinsertion for an extremely rare complication[J]. Perit Dial Int, 2017, 37 (2): 237- 239.
doi: 10.3747/pdi.2016.00031
4 Schwetz I , Horina J , Buzina W , et al. Aspergillus oryzae peritonitis in CAPD: Case report and review of the literature[J]. Am J Kidney Dis, 2007, 49 (5): 701- 704.
doi: 10.1053/j.ajkd.2007.02.260
5 De Bernardis F , Mondello F , San Millan R , et al. Biotyping and virulence properties of skin isolates of Candida parapsilosis[J]. J Clin Microbiol, 1999, 37 (11): 3481- 3486.
doi: 10.1128/JCM.37.11.3481-3486.1999
6 Almirante B , Rodriguez D , Cuenca-Estrella M , et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis blood stream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003[J]. J Clin Microbiol, 2006, 44 (5): 1681- 1685.
doi: 10.1128/JCM.44.5.1681-1685.2006
7 Branchini ML , Pfaller MA , Rhine-Chalberg J , et al. Genotypic variation and slime production among blood and catheter risolates of Candida parapsilosis[J]. J Clin Microbiol, 1994, 32 (2): 452- 456.
doi: 10.1128/jcm.32.2.452-456.1994
8 Pfaller MA , Diekema DJ . Epidemiology of invasive candidiasis: A persistent public health problem[J]. Clin Microbiol Rev, 2007, 20 (1): 133- 163.
doi: 10.1128/CMR.00029-06
9 Piraino B , Bailie GR , Bernardini J , et al. ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update[J]. Perit Dial Int, 2005, 25 (2): 107- 131.
doi: 10.1177/089686080502500203
10 Li PK , Szeto CC , Piraino B , et al. International society for peritoneal dialysis. Peritoneal dialysis-related infections recommendations: 2010 update[J]. Perit Dial Int, 2010, 30 (4): 393- 423.
doi: 10.3747/pdi.2010.00049
11 Schaefer F , Klaus G , Müller-Wiefel DE , et al. Intermittent versus continuous intraperitoneal glycopeptide /ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS)[J]. J Am Soc Nephrol, 1999, 10 (1): 136- 145.
doi: 10.1681/ASN.V101136
12 Swartz SJ , Neu A , Skversky Mason A , et al. Exit site and tunnel infections in children on chronic peritoneal dialysis: Findings from the standardizing care to improve outcomes in pediatric end stage renal disease (SCOPE) collaborative[J]. Pediatr Nephrol, 2018, 33 (6): 1029- 1035.
doi: 10.1007/s00467-018-3889-3
13 Bernardini J , Bender F , Florio T , et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients[J]. J Am Soc Nephrol, 2005, 16 (2): 539- 545.
doi: 10.1681/ASN.2004090773
14 Ramage G , Martinez JP , Lopez-Ribot JL . Candida biofilms on implanted biomaterials: A clinically significant problem[J]. FEMS Yeast Res, 2006, 6 (7): 979- 986.
doi: 10.1111/j.1567-1364.2006.00117.x
15 Prasad N , Gupta A . Fungal peritonitis in peritoneal dialysis patients[J]. Perit Dial Int, 2005, 25 (3): 207- 222.
doi: 10.1177/089686080502500302
16 Li PK , Szeto CC , Piraino B , et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int, 2016, 36 (5): 481- 508.
doi: 10.3747/pdi.2016.00078
[1] 侯婉音,董捷. 腹膜透析患者获得性肾囊肿出血3例[J]. 北京大学学报(医学版), 2024, 56(3): 546-550.
[2] 段丽萍,郑朝霞,张宇慧,董捷. 腹膜透析患者营养不良-炎症-心血管疾病与认知功能恶化的关系[J]. 北京大学学报(医学版), 2019, 51(3): 510-518.
[3] 唐雯,高峻逸,马辛宇,张超贺,马连韬,王亚沙. 循环神经网络模型在腹膜透析临床预后预测中的初步应用[J]. 北京大学学报(医学版), 2019, 51(3): 602-608.
[4] 丁艳苓,沈宁,周庆涛,贺蓓,郑佳佳,赵心懋. 非免疫缺陷宿主念珠菌血流感染[J]. 北京大学学报(医学版), 2018, 50(6): 1063-1069.
[5] 倪莲芳,王鹤,李虹,张志刚,刘新民. 非人类免疫缺陷病毒感染肺隐球菌病34例临床分析[J]. 北京大学学报(医学版), 2018, 50(5): 855-860.
[6] 蔡士铭,燕宇,赵慧萍,武蓓,左力,王梅. 腹膜透析相关嗜酸粒细胞性腹膜炎1例报道并文献复习[J]. 北京大学学报(医学版), 2018, 50(4): 747-751.
[7] 李相友,伍军,罗丹,陈晚先,朱戈丽,张艳霞,毕智敏,封宝红. 高糖腹膜透析液对人腹膜间皮细胞NLRP3-IL-1β的影响[J]. 北京大学学报(医学版), 2017, 49(6): 954-960.
[8] 张欣, 茹喜芳, 王颖, 李星, 桑田, 冯琪. 新生儿重症监护病房中新生儿真菌败血症的临床特点[J]. 北京大学学报(医学版), 2017, 49(5): 789-793.
[9] 丁宁, 闫志敏, 华红. 实时荧光定量PCR法检测原发性Sjögren综合征口腔真菌菌群[J]. 北京大学学报(医学版), 2013, 45(1): 17-21.
[10] 史均宝, 孙庆华, 聂建东, 孙玲华, 张凝, 韩庆烽. 糖尿病腹膜透析患者下肢动脉硬化闭塞症的临床状况分析[J]. 北京大学学报(医学版), 2013, 45(1): 109-113.
[11] 黎丽娴*, 唐雯, 陈伯钧, 汪涛. 腹膜透析患者血压状态与心率变异性关系的横断面研究[J]. 北京大学学报(医学版), 2011, 43(6): 849-854.
[12] 杨志凯, 董捷, 左力. 腹膜透析总水清除量下降速率快是患者死亡的独立危险因素[J]. 北京大学学报(医学版), 2011, 43(6): 844-848.
[13] 马彦*, 乔建军, 刘伟, 李若瑜. 烟曲霉sho1基因对渗透压传导的作用和抗真菌药物敏感性的影响[J]. 北京大学学报(医学版), 2009, 41(2): 162-167.
[14] 林志彬, 王鹏云. 灵芝孢子及其活性成分的药理研究[J]. 北京大学学报(医学版), 2006, 38(5): 541-547.
[15] 李东明, 李若瑜, 王晓红, 万喆, 马圣清, 王端礼. 甄氏外瓶霉的核糖体基因分型研究[J]. 北京大学学报(医学版), 2005, 37(2): 167-171.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!